+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Effect of fish oil supplementation on insulin secretion and insulin action in patients with Type II (non-insulin-dependent) diabetes

Casopis Lekaru Ceskych 131(22): 668-672

Effect of fish oil supplementation on insulin secretion and insulin action in patients with Type II (non-insulin-dependent) diabetes

For 3 weeks, the diet given to mildly obese, normotriglyceridaemic men with non-insulin-dependent diabetes mellitus and treated with hypoglycaemic agents, was supplemented with a fish oil concentrate at 15 ml/head, equivalent to a daily intake of n-3 fatty acids (FA) 3.1 g. A control group received 15 ml saline daily.

(PDF 0-2 workdays service: $29.90)

Accession: 002355847

Related references

Insulin therapy in obese, non-insulin-dependent diabetes induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawal. Diabetes 33(7): 634-642, 1984

Dietary fish oil augments insulin secretion and insulin clearance in obese and type 2 non insulin dependent diabetic patients. Diabetologia 31(7): 532A, 1988

Effect of high sucrose diet on insulin secretion and insulin action. A study in rats with non-insulin-dependent diabetes induced by streptozotocin. Diabetologia 30(8): 666-673, 1987

Insulin, glibenclamide or metformin treatment for non insulin dependent diabetes: heterogenous responses of standard measures of insulin action and insulin secretion before and after differing hypoglycaemic therapy. Diabetes Research 19(2): 69-76, 1992

The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes 34(3): 222-234, 1985

Peripheral insulin and endogenous insulin secretion in type 2 non insulin dependent diabetes mellitus before and during insulin treatment. Diabetologia 31(7): 514A-515A, 1988

Effect of sulfonylurea treatment on in vivo insulin secretion and action in patients with non-insulin-dependent diabetes mellitus. Diabetes 31(4 Pt 1): 307-312, 1982

Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues. Diabetes Care 7 Suppl 1: 89-99, 1984

Partial recovery of insulin secretion and action after combined insulin-sulfonylurea treatment in type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral agents. Diabetologia 33(11): 688-695, 1990

Seasonality of type 1 insulin dependent diabetes mellitus values of c peptide insulin antibodies and hemoglobin a 1c show evidence of a more rapid loss of insulin secretion in epidemic patients. Diabetologia 32(2): 84-91, 1989